Stay updated with breaking news from Martin Prlic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Seattle, WA (PRWEB) December 20, 2022 -- Last year, Washington Research Foundation (WRF) and Fred Hutchinson Cancer Center (Fred Hutch) launched a new
Fred Hutch scientists have identified a subset of immune-calming T cells that show up in great numbers in head and neck cancers, but not in similar tissues inflamed by gum diseases. This odd group of T cells have somehow been tricked into protecting these solid tumors from immune assault, but now might be precisely targeted by drugs to lift that protective shield.
Researchers have discovered that solid tumors misuse a type of T cell, which protects them from the immune system.
Fred Hutch immunologist Dr. Jennifer Lund knows that regulatory T cells, or T-regs, have an outsized and underappreciated role maintaining health and fighting disease. Her work shows how T-regs contribute to immunity to viral infections like COVID-19, HIV, West Nile Virus, Zika and herpes. In fact, it all started with herpes.
Fred Hutch immunologist Dr. Jennifer Lund knows that regulatory T cells, or T-regs, have an outsized and underappreciated role maintaining health and fighting disease. Her work shows how T-regs contribute to immunity to viral infections like COVID-19, HIV, West Nile Virus, Zika and herpes. In fact, it all started with herpes.